Vaccination of Pregnant Women, Seniors, and Adults at High Risk in the Île-de-France Region in 2025
Key Points
For Pregnant Women
Four vaccinations are recommended: vaccinations against whooping cough, the flu, COVID-19, and respiratory syncytial virus (RSV). These vaccinations help protect both the pregnant woman and the newborn while the baby is waiting for its first vaccinations—a time when it is most vulnerable to infections. The measles, mumps, and rubella (MMR) vaccine (live-attenuated) is not recommended during pregnancy and should be administered beforehand.
In 2025, nearly 65% of women who gave birth in the region had been vaccinated against pertussis. This vaccination coverage has risen sharply since 2023 (+29 percentage points).
During the 2025–2026 RSV immunization campaign, 49% of eligible pregnant women in the Île-de-France region were vaccinated against RSV. This figure represents a significant increase compared to the 2024–2025 campaign (+21 percentage points), when this vaccination was first implemented. If the mother was not vaccinated against RSV during pregnancy, the infant can be protected from birth through an injection of monoclonal antibodies.
For people aged 65 and older
Vaccinations against pneumococcal disease and shingles have been recommended for everyone since 2025, in addition to vaccinations against seasonal flu, COVID-19, and booster shots against diphtheria, tetanus, and polio (DTP). Vaccination against RSV infections is also recommended for people aged 75 and older, as well as for those between the ages of 65 and 74 with chronic respiratory or cardiac conditions. These vaccinations are part of a strategy to protect older adults against respiratory infections, which are responsible for numerous hospitalizations and complications such as cardiovascular events, cognitive decline, and loss of independence.
In the region, flu vaccination coverage among people aged 65 and older increased by nearly 3 percentage points—for the first time since the COVID-19 pandemic—with 56% of people vaccinated during the 2025–2026 season. However, it still falls short of the 75% target set by the World Health Organization (WHO).
In the Île-de-France region, 24% of people aged 65 and older at high risk for pneumococcal infections were properly vaccinated against pneumococcal infections in 2025. Furthermore, only 9% of people aged 65 and older were vaccinated against shingles in 2025.
Among residents and staff working in long-term care facilities for dependent older adults
Vaccinations against the flu and COVID-19 are recommended in addition to preventive measures to protect the most vulnerable individuals.
Among residents in long-term care facilities, flu vaccination coverage was high, with 85% of them vaccinated during the 2025–2026 season—exceeding the 75% threshold recommended by the WHO. COVID-19 vaccination coverage, however, was lower, estimated at 65%.
Among healthcare professionals working in nursing homes, flu vaccination coverage remained insufficient, with only 27% vaccinated despite recommendations, although there was a slight upward trend during the 2025–2026 season.
Vaccination Acceptance
Vaccination acceptance remained high in the region, particularly among older adults, with 85% of those aged 65 to 79 stating they were in favor of vaccination in general.
In relation to
Vaccination
thematic dossier
Contagious diseases most often affect children at a very young age. Because children are particularly vulnerable, they are a priority target for vaccination programs.
news
Seniors, pregnant women, and nursing home staff: What is the status of their ...
Our latest news
news
Odissé Dataviz Challenge: Winners Honored at the Santé publique France...
news
Call for Nominations to Fill Vacancies on the National Reference Centers...
news